The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Does incidence of rash predict treatment response to lapatanib in breast cancer?
J. M. Parma
No relevant relationships to disclose
A. C. Pavlick
No relevant relationships to disclose
J. C. N. Chang
No relevant relationships to disclose
M. F. Rimawi
Research Funding - GlaxoSmithKline
M. Trivedi
No relevant relationships to disclose